Antibiotics

Verticillin A is originally isolated from Verticillium sp. Tm-759. It has the effect of anti-gram-positive bacteria, mycobacterium and protozoa, and has the inhibitory effect on the cancer of Ascites.

Verticillin C is originally isolated from Verticillium sp. Tm-759. It has the effect of anti-gram-positive bacteria, mycobacterium and protozoa, and has the inhibitory effect on the cancer of Ascites.

Acetyloxycycloheximide is originally isolated from Streptomyces albulus ACTT 12757. When the concentration was 0.05-0.25 mg/kg, it could inhibit sarcoma 180 in mice, and its antifungal and antiyeast activities were very weak.

It is an antibiotic produced by the strain of Str. albus 80614. It has anti-gram-positive bacteria and mycobacterium effects. It also has the effect against gram-negative bacteria and fungi but the effect is weak. It has a therapeutic effect on chickens infected with coccidiococci.

Salinomycin Sodium is an antibiotic produced by the strain of Str. albus 80614. It has anti-gram-positive bacteria and mycobacterium effects. It also has the effect against gram-negative bacteria and fungi but the effect is weak. It has a therapeutic effect on chickens infected with coccidiococci. It can be used to prevent chicken coccidiosis.

Sangivamycin is a nucleoside (purine) antibiotic produced by the strain of Str. rimosus BA-90912. 0.02-0.05 μg/mL of Sangivamycin inhibits HeLa cells. It has weak inhibitory effect on sarcoma-180 and adenocarcinoma 755 in mice. It has obvious inhibitory effect on leukemia L-1210. When intraperitoneally administered, the drug binds to nucleic acids in tissues in mice through phosphorylation.

It is produced by the strain of Str. nodosus MH190-16F3. It has antimicrobial effect, but it has weaker effect against gram-negative bacteria. It has inhibitory effect on leukemia P388 cells and adriamycin-resistant P388 cells.

It is produced by the strain of Str. pseudovenezuelae AM-2947. It has anti-gram-positive bacteria and mycobacteria effects, and has the effect of inhibiting sarcoma-180.

Showdomycin is a nucleoside antibiotic produced by the strain of Str. showdoensis Z-452. It has anti-bacterial effect. 5-15 mg/(kg.d) of Showdomycin can inhibit Ehrlich ascites cancer. It is also cytotoxic to HeLa cells.

It is a terpene antibiotic roduced by the strain of Helminthosporium siccans BH-34. It has activity against gram-negative bacteria, mycobacteria and fungi.

It is an aminoglycoside antibiotic produced by the strain of Micromonospora inyoensis NRRL 3292. It has a broad-spectrum antibacterial effects against Gram-positive and Gram-negative bacteria including B. subtilis, S. aureus, E. coli, and P. aeruginosa. It has no cross-resistance to kanamycin, but has cross-resistance to gentamycin. 50 mg/kg of Sisomicin has protective effect on mice infected with Rickettsia spinosa.

It is an anti-tumor drug produced by the strain of Str. sparsogenes var. sparsogenes NRRL 2940, Str. cuspidosporus B-79. It has the effect of anti-bacterial and a few fungi. 0.05 μg/mL of Sparsomycin can inhibit the synthesis of 50% KB cell protein, it has the inhibitory effect on 11 kinds of experimental tumor, such as sarcoma-180 solid type, sarcoma-180 ascites type and Eschericz ascites carcinoma.

It is produced by the strain of Bacillus sp. BMG 162-aF2. It has anti-gram-positive bacteria and negative bacteria effects. Spergualin of 1.56-25.0 mg/(kg.d) in mice with intraperitoneal infection of leukemia L-1210 has a life-prolonging effect, Spergualin of 6.25 mg/(kg.d) can survive all animals at 60 days. Spergualin of 12.5-50 mg/(kg.d) (subcutaneous inoculation, intraperitoneal administration) in mice with Leukemia L-1210 (solid type) can survive all animals in the 3 groups at 30 days.

It is produced by the strain of Pen. spinulosurn, Pen. cinerascens, Asp. fumigatas. It has anti-bacterial effect, but the effect is not strong.

It is a macrolide antibiotic produced by the strain of Str. ambofaciens. It has strong anti-gram-positive bacteria activity, but has weak anti-Gram-negative bacteria and mycobacteria activity. Its antibacterial activity is close to other components. It has partial cross-resistance with erythromycin, carbomycin and picromycin. Its activity is stronger in alkaline condition, and it is more active in vivo than in vitro. It is also effective against scrub typhus fever and rickettsia.

It is a macrolide antibiotic produced by the strain of Str. ambofaciens. It has strong anti-gram-positive bacteria activity, but has weak anti-Gram-negative bacteria and mycobacteria activity. Its antibacterial activity is close to other components. It has partial cross-resistance with erythromycin, carbomycin and picromycin. Its activity is stronger in alkaline condition, and it is more active in vivo than in vitro. It is also effective against scrub typhus fever and rickettsia.

It is a macrolide antibiotic produced by the strain of Str. ambofaciens. It has strong anti-gram-positive bacteria activity, but has weak anti-Gram-negative bacteria and mycobacteria activity. Its antibacterial activity is close to other components. It has partial cross-resistance with erythromycin, carbomycin and picromycin. Its activity is stronger in alkaline condition, and it is more active in vivo than in vitro. It is also effective against scrub typhus fever and rickettsia.

It is a macrolide antibiotic produced by the strain of Saccaropolyspora sp. L53-18. It has anti-Gram-positive bacteria effect, but no anti-Gram-negative bacteria effect. It has cross-resistance with macrolide antibiotics.

It is a macrolide antibiotic produced by the strain of Saccaropolyspora sp. L53-18. It has anti-Gram-positive bacteria effect, but no anti-Gram-negative bacteria effect. It has cross-resistance with macrolide antibiotics.

It is a macrolide antibiotic produced by the strain of Saccaropolyspora sp. L53-18. It has anti-Gram-positive bacteria effect, but no anti-Gram-negative bacteria effect. It has cross-resistance with macrolide antibiotics.